William Blair analyst Matt Larew has maintained their neutral stance on MRVI stock, giving a Hold rating yesterday.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Matt Larew has given his Hold rating due to a combination of factors, including meaningful operational progress alongside still-evolving fundamentals. Management’s restructuring and tighter controls have stabilized the company, revived commercial execution, and supported new product launches just as demand indicators in its core markets begin to improve, allowing Maravai to return to non-COVID growth and achieve positive adjusted EBITDA earlier than anticipated.
At the same time, overall revenue is still declining year-over-year and key segments, such as TriLink, remain under pressure despite beating expectations, which tempers the near-term growth profile. While the 2026 outlook for revenue and profitability is encouraging and the current valuation at roughly 4.6 times his 2026 sales estimate appears reasonable, Larew views the risk/reward as balanced for now and prefers to wait for additional execution proof points before adopting a more constructive stance.

